ScholarIQanswers from OpenAlex

Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer

PaperCitations, authors & open-access status

Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer have?

ScholarIQcitation count

Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer has 172 citations in the OpenAlex counts ScholarIQ stores.

When was Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer published?

ScholarIQyear

Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer has 2019 year in the ScholarIQ index.

What is the open-access status of Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer?

ScholarIQoa status

Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer has gold oa status in the ScholarIQ index.

What is the DOI of Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer?

ScholarIQdoi

The DOI for Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer is on the source record.

What is the PMID of Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer?

ScholarIQpmid

The PMID for Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer is on the source record.

What is the OpenAlex record for Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer?

ScholarIQopenalex

The OpenAlex for Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial